Atopic Dermatitis - Eczema
Clinics, Pathophysiology and Therapy
Page
%P
-
Chapter
Concluding Remarks: How To Live With Eczema/Atopic Dermatitis
The many informations and commentaries in this book, starting from the clinical morphology and epidemiology via pathophysiology, diagnostics, therapy, and prevention, make clear that atopic dermatitis is a ver...
-
Chapter
Burden of Disease in Atopic Eczema
The individual burden for a patient with atopic eczema consists of dysesthesia—with intense itch sensations but also pain—loss of function if the hands or feet are affected, social stigmatization and disfigure...
-
Chapter
Outlook into the Future
The last century brought us enormous insights into the pathogenesis, the clinical course, comorbidities, the stigmatization, and loss of quality of life of patients suffering from atopic dermatitis as well as ...
-
Chapter
Nummular Eczema: An Update
Nummular eczema is characterized by a chronic noninfectious inflammation of the epidermis and dermis and single or multiple coin-shaped, well-demarcated lesions. It undergoes the common eczema stages: initial ...
-
Book
-
Chapter
General Introduction and History
The prevalence of atopic dermatitis/eczema has increased during the last decades; however, the diseases probably have been around for four centuries. The term “eczema” was first used by the Greek Aetius from A...
-
Chapter
Etiopathophysiology of Atopic Eczema
In the etiopathophysiology of atopic eczema, genetic and environmental influences play an important role. Three aspects are the focus of current research: the disturbed skin barrier function illustrated by mut...
-
Chapter
Special Therapeutic Options and Substances in the Treatment of Atopic Eczema
Among special therapeutic options, anti-inflammatory treatment using topical glucocorticosteroids (TCS) or topical calcineurin inhibitors (TCI) are core elements. Antimicrobial therapy using preferably antisep...
-
Chapter
Epidemiology of Atopic Eczema
Atopic eczema is one of the most common noncommunicable inflammatory skin diseases, especially in childhood. Epidemiological studies have shown prevalence rates of 5–20% among preschool children. In adults, pr...
-
Chapter
Clinical Symptomatology of Atopic Eczema
The clinical symptomatology of atopic eczema comprises a colorful spectrum of skin lesions from infiltrated erythema, erosive excoriated lesions, and lichenified areas to pruriginous papules and nodules going ...
-
Chapter
General Management of Patients with Atopic Eczema
The general management of patients with atopic eczema comprises special diagnostic procedures with a focus on allergy diagnostics using skin tests such as cutaneous (prick) or epicutaneous (classic patch test ...
-
Chapter
Prevention
In recommendations for prevention, one has to differentiate between primary, secondary, and tertiary prevention. Primary prevention is relevant for the whole population; for allergy.
-
Chapter
Allergy and Civilization
is an alteration of immunological reactivity leading to hypersensitivity disease with inflammation of skin and mucous membranes up to life-threatening generalized reactions have increased in prevalence worl...
-
Reference Work Entry In depth
Immediate-Type Allergy: Rhinoconjunctivitis, Asthma, Anaphylaxis
Immediate-type allergies have increased significantly in frequency in the last decades of the twentieth century, but the causes of this have ultimately not been clarified. The following prevalence, moderately ...
-
Chapter
History of Allergy: Clinical Descriptions, Pathophysiology, and Treatment
Allergy has shown a dramatic increase in prevalence in the last decades. However, allergic diseases are probably not new. Asthma and eczema have been described in ancient societies like Egypt, China and in the...
-
Article
Open AccessWhite paper on peanut allergy – part 1: Epidemiology, burden of disease, health economic aspects
Peanuts are Leguminosae, commonly known as the legume or pea family, and peanut allergy is among the most common food allergies and the most common cause of fatal food reactions and anaphylaxis.
-
Article
White Paper Erdnussallergie - Teil 1: Epidemiologie, Burden of Disease, gesundheitsökonomische Aspekte
-
Article
Open AccessStellungnahme zum Einsatz von topisch-inhalativem Budesonid bei COVID-19-Infektion
-
Article
Open AccessRecommendations for use of topical inhalant budesonide in COVID-19
-
Article
Open AccessImmunologically relevant aspects of the new COVID-19 vaccines—an ÖGAI (Austrian Society for Allergology and Immunology) and AeDA (German Society for Applied Allergology) position paper
The vaccines against the coronavirus disease 2019 (COVID-19) approved in the European Union represent a decisive step in the fight against the pandemic. The application of these available vaccines to patients ...
